Report cover image

Global Domperidone Tablets Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 195 Pages
SKU # APRC20280284

Description

Summary

According to APO Research, the global Domperidone Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Domperidone Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Domperidone Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Domperidone Tablets market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Domperidone Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Domperidone Tablets market include Foshan Chiral Pharmaceutical, Hansoh Pharmaceutical, Livzon Pharmaceutical, Weiao Pharmaceutical, Changzhou Pharmaceutical Factory, Johnson & Johnson and Shanghai Sine Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Domperidone Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Domperidone Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Domperidone Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Domperidone Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Domperidone Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Domperidone Tablets sales, projected growth trends, production technology, application and end-user industry.

Domperidone Tablets Segment by Company

Foshan Chiral Pharmaceutical
Hansoh Pharmaceutical
Livzon Pharmaceutical
Weiao Pharmaceutical
Changzhou Pharmaceutical Factory
Johnson & Johnson
Shanghai Sine Pharmaceutical
Domperidone Tablets Segment by Type

Original Drug
Generic Drug
Domperidone Tablets Segment by Application

Hospital and Clinic
Pharmacy
Domperidone Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Domperidone Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Domperidone Tablets market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Domperidone Tablets significant trends, drivers, influence factors in global and regions.
6. To analyze Domperidone Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Domperidone Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Domperidone Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Domperidone Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Domperidone Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Domperidone Tablets industry.
Chapter 3: Detailed analysis of Domperidone Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Domperidone Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Domperidone Tablets in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Domperidone Tablets Sales Value (2020-2031)
1.2.2 Global Domperidone Tablets Sales Volume (2020-2031)
1.2.3 Global Domperidone Tablets Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Domperidone Tablets Market Dynamics
2.1 Domperidone Tablets Industry Trends
2.2 Domperidone Tablets Industry Drivers
2.3 Domperidone Tablets Industry Opportunities and Challenges
2.4 Domperidone Tablets Industry Restraints
3 Domperidone Tablets Market by Company
3.1 Global Domperidone Tablets Company Revenue Ranking in 2024
3.2 Global Domperidone Tablets Revenue by Company (2020-2025)
3.3 Global Domperidone Tablets Sales Volume by Company (2020-2025)
3.4 Global Domperidone Tablets Average Price by Company (2020-2025)
3.5 Global Domperidone Tablets Company Ranking (2023-2025)
3.6 Global Domperidone Tablets Company Manufacturing Base and Headquarters
3.7 Global Domperidone Tablets Company Product Type and Application
3.8 Global Domperidone Tablets Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Domperidone Tablets Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Domperidone Tablets Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Domperidone Tablets Market by Type
4.1 Domperidone Tablets Type Introduction
4.1.1 Original Drug
4.1.2 Generic Drug
4.2 Global Domperidone Tablets Sales Volume by Type
4.2.1 Global Domperidone Tablets Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Domperidone Tablets Sales Volume by Type (2020-2031)
4.2.3 Global Domperidone Tablets Sales Volume Share by Type (2020-2031)
4.3 Global Domperidone Tablets Sales Value by Type
4.3.1 Global Domperidone Tablets Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Domperidone Tablets Sales Value by Type (2020-2031)
4.3.3 Global Domperidone Tablets Sales Value Share by Type (2020-2031)
5 Domperidone Tablets Market by Application
5.1 Domperidone Tablets Application Introduction
5.1.1 Hospital and Clinic
5.1.2 Pharmacy
5.2 Global Domperidone Tablets Sales Volume by Application
5.2.1 Global Domperidone Tablets Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Domperidone Tablets Sales Volume by Application (2020-2031)
5.2.3 Global Domperidone Tablets Sales Volume Share by Application (2020-2031)
5.3 Global Domperidone Tablets Sales Value by Application
5.3.1 Global Domperidone Tablets Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Domperidone Tablets Sales Value by Application (2020-2031)
5.3.3 Global Domperidone Tablets Sales Value Share by Application (2020-2031)
6 Domperidone Tablets Regional Sales and Value Analysis
6.1 Global Domperidone Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Domperidone Tablets Sales by Region (2020-2031)
6.2.1 Global Domperidone Tablets Sales by Region: 2020-2025
6.2.2 Global Domperidone Tablets Sales by Region (2026-2031)
6.3 Global Domperidone Tablets Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Domperidone Tablets Sales Value by Region (2020-2031)
6.4.1 Global Domperidone Tablets Sales Value by Region: 2020-2025
6.4.2 Global Domperidone Tablets Sales Value by Region (2026-2031)
6.5 Global Domperidone Tablets Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Domperidone Tablets Sales Value (2020-2031)
6.6.2 North America Domperidone Tablets Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Domperidone Tablets Sales Value (2020-2031)
6.7.2 Europe Domperidone Tablets Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Domperidone Tablets Sales Value (2020-2031)
6.8.2 Asia-Pacific Domperidone Tablets Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Domperidone Tablets Sales Value (2020-2031)
6.9.2 South America Domperidone Tablets Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Domperidone Tablets Sales Value (2020-2031)
6.10.2 Middle East & Africa Domperidone Tablets Sales Value Share by Country, 2024 VS 2031
7 Domperidone Tablets Country-level Sales and Value Analysis
7.1 Global Domperidone Tablets Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Domperidone Tablets Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Domperidone Tablets Sales by Country (2020-2031)
7.3.1 Global Domperidone Tablets Sales by Country (2020-2025)
7.3.2 Global Domperidone Tablets Sales by Country (2026-2031)
7.4 Global Domperidone Tablets Sales Value by Country (2020-2031)
7.4.1 Global Domperidone Tablets Sales Value by Country (2020-2025)
7.4.2 Global Domperidone Tablets Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.5.2 USA Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Canada Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.8.2 Germany Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.9.2 France Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.9.3 France Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.11.2 Italy Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.12.2 Spain Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.13.2 Russia Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.16.2 China Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.16.3 China Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.17.2 Japan Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.19.2 India Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.19.3 India Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.20.2 Australia Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.24.2 Chile Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.26.2 Peru Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.28.2 Israel Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.29.2 UAE Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.31.2 Iran Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Domperidone Tablets Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Domperidone Tablets Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Domperidone Tablets Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Foshan Chiral Pharmaceutical
8.1.1 Foshan Chiral Pharmaceutical Comapny Information
8.1.2 Foshan Chiral Pharmaceutical Business Overview
8.1.3 Foshan Chiral Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2020-2025)
8.1.4 Foshan Chiral Pharmaceutical Domperidone Tablets Product Portfolio
8.1.5 Foshan Chiral Pharmaceutical Recent Developments
8.2 Hansoh Pharmaceutical
8.2.1 Hansoh Pharmaceutical Comapny Information
8.2.2 Hansoh Pharmaceutical Business Overview
8.2.3 Hansoh Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2020-2025)
8.2.4 Hansoh Pharmaceutical Domperidone Tablets Product Portfolio
8.2.5 Hansoh Pharmaceutical Recent Developments
8.3 Livzon Pharmaceutical
8.3.1 Livzon Pharmaceutical Comapny Information
8.3.2 Livzon Pharmaceutical Business Overview
8.3.3 Livzon Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2020-2025)
8.3.4 Livzon Pharmaceutical Domperidone Tablets Product Portfolio
8.3.5 Livzon Pharmaceutical Recent Developments
8.4 Weiao Pharmaceutical
8.4.1 Weiao Pharmaceutical Comapny Information
8.4.2 Weiao Pharmaceutical Business Overview
8.4.3 Weiao Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2020-2025)
8.4.4 Weiao Pharmaceutical Domperidone Tablets Product Portfolio
8.4.5 Weiao Pharmaceutical Recent Developments
8.5 Changzhou Pharmaceutical Factory
8.5.1 Changzhou Pharmaceutical Factory Comapny Information
8.5.2 Changzhou Pharmaceutical Factory Business Overview
8.5.3 Changzhou Pharmaceutical Factory Domperidone Tablets Sales, Value and Gross Margin (2020-2025)
8.5.4 Changzhou Pharmaceutical Factory Domperidone Tablets Product Portfolio
8.5.5 Changzhou Pharmaceutical Factory Recent Developments
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Comapny Information
8.6.2 Johnson & Johnson Business Overview
8.6.3 Johnson & Johnson Domperidone Tablets Sales, Value and Gross Margin (2020-2025)
8.6.4 Johnson & Johnson Domperidone Tablets Product Portfolio
8.6.5 Johnson & Johnson Recent Developments
8.7 Shanghai Sine Pharmaceutical
8.7.1 Shanghai Sine Pharmaceutical Comapny Information
8.7.2 Shanghai Sine Pharmaceutical Business Overview
8.7.3 Shanghai Sine Pharmaceutical Domperidone Tablets Sales, Value and Gross Margin (2020-2025)
8.7.4 Shanghai Sine Pharmaceutical Domperidone Tablets Product Portfolio
8.7.5 Shanghai Sine Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Domperidone Tablets Value Chain Analysis
9.1.1 Domperidone Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Domperidone Tablets Sales Mode & Process
9.2 Domperidone Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Domperidone Tablets Distributors
9.2.3 Domperidone Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.